Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature
- 1 November 2003
- journal article
- research article
- Published by Cambridge University Press (CUP) in Journal of the International Neuropsychological Society
- Vol. 9 (7) , 967-982
- https://doi.org/10.1017/s1355617703970019
Abstract
A meta-analysis was conducted to evaluate possible neuropsychological effects of treatments for cancer in adults. A search revealed 30 studies, encompassing 29 eligible samples, and leading to inclusion of a total of 838 patients and control participants. A total of 173 effect sizes (Cohen's d) were extracted across 7 cognitive domains and as assessed in the literature via 3 methods of comparison (post-treatment compared with normative data, controls, or baseline performance). Statistically significant negative effect sizes were found consistently across both normative and control methods of comparison for executive function, verbal memory, and motor function. The largest effects were for executive function and verbal memory normative comparisons (−.93 and −.91, respectively). When limiting the sample of studies in the analyses to only those with relatively “less severe” diagnoses and treatments, the effects remained. While these results point toward some specific cognitive effects of systemic cancer therapies in general, no clear clinical implications can yet be drawn from these results. More research is needed to clarify which treatments may produce cognitive decrements, the size of those effects, and their duration, while ruling out a wide variety of possible mediating or moderating variables. (JINS, 2003, 9, 967–982.)Keywords
This publication has 69 references indexed in Scilit:
- Cognitive Function and Reproductive Hormones in Adjuvant Therapy for Breast CancerJournal of Pain and Symptom Management, 2001
- Neuropsychology of chronic fatigue syndrome: A critical reviewJournal of Clinical and Experimental Neuropsychology, 1997
- The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessmentsEuropean Journal Of Cancer, 1996
- Neurological and cognitive impairment in long-term survivors of small cell lung cancerEuropean Journal Of Cancer, 1994
- Cognitive functioning in long-term survivors of high-grade gliomaJournal of Neurosurgery, 1994
- Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administrationEuropean Journal Of Cancer, 1993
- Minimal neuropsychological sequelae following prophylactic treatment of the central nervous system in adult leukaemia and lymphomaBritish Journal of Cancer, 1989
- Quality of Life Among Survivors of Childhood CancerJournal of Psychosocial Oncology, 1987
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985
- Neuropsychiatric effects of chemotherapeutic agents for cancerPsychosomatics, 1980